Evidence supporting the use of: Catecholamine
For the health condition: Attention Deficit Disorder

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 5

Catecholamines, including dopamine and norepinephrine, play a central role in the neurobiology of Attention Deficit Disorder (ADD), more commonly referred to as Attention Deficit Hyperactivity Disorder (ADHD). The primary pharmacological treatments for ADHD—such as methylphenidate (Ritalin) and amphetamines (Adderall)—work by increasing the synaptic availability of these catecholamines in the brain. Scientific evidence supports the hypothesis that individuals with ADHD have dysregulated catecholaminergic neurotransmission, particularly in the prefrontal cortex, which is crucial for attention, executive function, and impulse control.

Numerous randomized, controlled trials and meta-analyses have demonstrated that medications which increase catecholamine activity significantly improve core symptoms of ADHD, including inattention, hyperactivity, and impulsivity. The American Academy of Pediatrics, the American Psychiatric Association, and other authoritative bodies recommend stimulant medications (which modulate catecholamines) as first-line treatment for ADHD in school-aged children and adults. While "catecholamine (unspecified)" is not a medication itself, the therapeutic rationale and strong empirical support for targeting catecholaminergic systems in ADHD are well-established in the scientific literature. Thus, the use of drugs that enhance catecholamine function is considered a scientifically validated and evidence-based approach for managing ADHD.

More about Catecholamine
More about Attention Deficit Disorder

Products containing Catecholamine

We currently have no products on Vitabase that contain this ingredient.